Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany-Reference-Cited by-同舟云学术

Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany

Published:2024-09-01 Issue:9 Volume:184 Page:1002
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Vokinger Kerstin N.¹,Nussli Emanuel¹,Dusetzina Stacie B.²³

Affiliation:

1. Academic Chair for Regulation in Law, Medicine, and Technology, Faculty of Law and Faculty of Medicine, University of Zurich, Zurich, Switzerland

2. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee

3. Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

Abstract

This Viewpoint compares use and costs of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss between the US and 3 other peer countries.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2821260/jamainternal_vokinger_2024_vp_240016_1724793921.61889.pdf

Reference7 articles.

1. Medicare Part D coverage of antiobesity medications—challenges and uncertainty ahead.;Baig;N Engl J Med,2023

2. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss.;Sodhi;JAMA,2023

3. The cancer premium—explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study.;Serra-Burriel;EClinicalMedicine,2023

4. Abelson? R, Robbins? R. Six reasons why it’s so hard to get your weight-loss drugs. The New York Times. February 2, 2024. Accessed June 7, 2024. https://www.nytimes.com/2024/02/02/health/ozempic-wegovy-weight-loss-pharmacies.html

5. Dangerfield? K. Wegovy will be available for Canadians in spring 2024, company says. Global News. February 5, 2024. Accessed June 7, 2024. https://globalnews.ca/news/10272929/wegovy-canada-spring-2024/

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation and Reinitiation of GLP-1 Receptor Agonists Among US Adults with Overweight or Obesity;2024-07-29